A Phase I Study of Concurrent Radiotherapy and Tegafur, Gimeracil and Oteracil Potassium Capsule(S-1) as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Trial Profile

A Phase I Study of Concurrent Radiotherapy and Tegafur, Gimeracil and Oteracil Potassium Capsule(S-1) as Adjuvant Treatment for Stage II/III Operable Rectal Cancer.

Recruiting
Phase of Trial: Phase I

Latest Information Update: 28 Feb 2017

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Rectal cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 01 Dec 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
    • 30 Oct 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top